Year 2019, Volume 5, Issue 4, Pages 719 - 721 2019-07-04

Spinal malignant triton tumor in a patient with neurofibromatosis type 1

Sevgi Kulaklı [1] , Fazıl Kulaklı [2] , İlker Fatih Sarı [3] , Samet Tatlı [4] , İlker İlhanlı [5] , Canan Çelik [6]

41 101

No abstract available.



malignant triton tumor, Neurofibromatosis, spinal nerve
  • [1] Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am J Pathol 2011;178:1932-9.
  • [2] Engel EE, Brassesco MS, Valera ET, Barbosa MHN,Yamashita MEAS, Scrideli CA, et al. Clinico-genetic aspects of a pediatric non-neurofibromatosis type 1 malignant triton tumor with loss of chromosome X. Pediatr Blood Cancer 2012;59:1320-3.
  • [3] Kamran SC, Howard SA, Shinagare AB, Krajewski KM. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. EJSO 2013;39:46-52.
  • [4] McConnell YJ, Giacomantonio CA. Malignant triton tumors--complete surgical resection and adjuvant radiotherapy associated with improved survival. J Surg Oncol 2012;106:51-6.
  • [5] Lee MJ, Stephenson DA. Recent developments in neurofibromatosis type 1. Curr Opin Neurol 2007;20:135-41.
  • [6] Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol 2012;19:878-85.
  • [7] Grobmyer SR, Reith JD, Shahlaee A, Bush CH, Hochwald SN. Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations. J Surg Oncol 2008;97:340-9.
  • [8] Ferner RE, Gutmann DG. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1. Cancer Res 2002;62:1573-7.
  • [9] Moretti VM, Crawford EA, Staddon AP, Lackman RD, Ogilvie CM.. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy. Am J Clin Oncol 2011;34:417-21.
Primary Language en
Subjects Dermatology, Clinical Neurology, Oncology, Rehabilitation
Journal Section Letters to the Editor
Authors

Orcid: 0000-0001-7886-1060
Author: Sevgi Kulaklı (Primary Author)
Institution: Department of Dermatology, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey
Country: Turkey


Orcid: 0000-0003-0275-7093
Author: Fazıl Kulaklı (Primary Author)
Institution: Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey
Country: Turkey


Orcid: 0000-0002-7998-8992
Author: İlker Fatih Sarı
Institution: Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey
Country: Turkey


Orcid: 0000-0002-4050-0873
Author: Samet Tatlı
Institution: Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey
Country: Turkey


Orcid: 0000-0002-7998-8992
Author: İlker İlhanlı
Institution: Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey
Country: Turkey


Orcid: 0000-0001-9418-5840
Author: Canan Çelik
Institution: Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey
Country: Turkey


Dates

Publication Date: July 4, 2019

EndNote %0 The European Research Journal Spinal malignant triton tumor in a patient with neurofibromatosis type 1 %A Sevgi Kulaklı , Fazıl Kulaklı , İlker Fatih Sarı , Samet Tatlı , İlker İlhanlı , Canan Çelik %T Spinal malignant triton tumor in a patient with neurofibromatosis type 1 %D 2019 %J The European Research Journal %P -2149-3189 %V 5 %N 4 %R doi: 10.18621/eurj.464297 %U 10.18621/eurj.464297